ASXL3 and Bohring-Opitz syndrome: Heterozygous de novo truncating variants in ASXL3 have recently been reported in 4 patients with a novel clinical phenotype similar to Bohring-Opitz syndrome, and are consistent with this patient’s clinical findings (Table 1, [23]).